Skip to main content
Equibles

ALPS ADVISORS INC

Position in VRDN — Viridian Therapeutics, Inc.\DE

CIK 1376113 Denver, CO
Back to VRDN Full portfolio

Position in VRDN

as of Jun 30, 2026 · filed Jul 29, 2026
Position Value
$2,049,577
+$1,187,219 QoQ
Shares Held
111,572
+179.2% QoQ
Ownership
0.098%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#82
of 215 holders
Holding Since
Jun 2022
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VRDN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ALPS ADVISORS INC holds $213,436,831 across 115 Biotechnology names. VRDN ranks #36 (1.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 315,335 $17,680,833
2 APGE
Apogee Therapeutics, Inc.
 62,523 $8,298,677
3 CGON
CG Oncology, Inc.
 89,218 $6,338,938
4 XENE
Xenon Pharmaceuticals Inc.
 97,610 $5,891,739
5 ORKA
Oruka Therapeutics, Inc.
 61,014 $5,806,702
6 DNTH
Dianthus Therapeutics, Inc. /DE/
 55,281 $5,388,791
7 TVTX
Travere Therapeutics, Inc.
 93,981 $5,339,060
8 DFTX
Definium Therapeutics, Inc.
 110,388 $5,192,651

All Filings in VRDN

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,049,577 111,572
2025-09-30 $862,358 39,961
2025-06-30 $614,686 43,969
2025-03-31 $828,723 61,478
2024-12-31 $1,227,972 64,057
2024-09-30 $1,065,268 46,825
2024-06-30 $647,455 49,766
2024-03-31 $775,272 44,276
2023-12-31 $759,120 34,854
2023-09-30 $494,899 32,262
2023-06-30 $754,309 31,707
2022-09-30 $427,592 20,848
2022-06-30 $191,599 16,560